Last November, after several hours of tough debate, the Massachusetts Medical Society's House of Delegates voted down a proposal that would give future editors of the society's New England Journal of Medicine (NEJM) complete control over the use and marketing of the prestigious journal's logo. Instead, in a concession to supporters of the journal's editors, the group agreed to set up a committee comprising deans of medical schools and schools of public health to arbitrate disputes between futur
 |
Those decisions represented the climax of a long struggle that had led the society to dismiss Jerome Kassirer, the journal's editor in chief, in July. "I thwarted many attempts to use the name of the NEJM on various Massachusetts Medical Society products," Kassirer wrote in a letter published in the Lancet, the British journal of medicine, on Sept. 4. The dismissal met ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
